Abel Hall LLC
ABUS icon

Abel Hall LLC’s Arbutus Biopharma ABUS Stock Holding History

Abel Hall LLC’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$88.7K Buy
18,547
+247
+1% +$1.19K 0.02% 792
2026
Q2 		$87.8K Sell
18,300
-1,773
-9% -$7.78K 0.02% 852
2026
Q1 		$90.3K Sell
20,073
-10,706
-35% -$46.8K 0.02% 699
2025
Q4 		$148K Buy
+30,779
New +$138K 0.03% 581

Other funds holding ABUS

Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Ledgewood Wealth Advisors
Ledgewood Wealth Advisors Exeter, New Hampshire $181M AUM 9.93% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Virginia Retirement Systems
Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return
Premier Path Wealth Partners
Premier Path Wealth Partners Madison, New Jersey $856M AUM 23.55% 1-Year Est. Return
State of Wyoming
State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Abel Hall LLC's ABUS Position: Q3 2026 in Review

Abel Hall LLC increased its Arbutus Biopharma (ABUS) stake by 1.3% in Q3 2026, buying an estimated $1.19K and bringing the position to 18,547 shares worth $88.7K. The position accounts for 0.02% of the portfolio, ranked #792.

Abel Hall LLC first reported a position in ABUS in Q4 2025 and has held it in 4 quarters since. The position peaked at $148K in Q4 2025. 34 funds tracked by Wall St. Rank hold ABUS as of Q3 2026.

  • Abel Hall LLC held 18,547 shares of Arbutus Biopharma worth $88.7K as of Q3 2026.
  • Abel Hall LLC bought 247 Arbutus Biopharma shares in Q3 2026, an estimated $1.19K.
  • Arbutus Biopharma made up 0.02% of Abel Hall LLC's portfolio in Q3 2026, its #792 holding.
  • Abel Hall LLC first reported a position in Arbutus Biopharma in Q4 2025 and has held it in 4 quarters since.
  • Abel Hall LLC's Arbutus Biopharma position peaked at $148K in Q4 2025.
  • 34 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.